Novartis Pharmaceuticals UK Limited UK Head Office Frimley Business Park Frimley Camberley Surrey GU16 7SR
+44 1276 692255 +44 1276 692508 Monday - Friday, 8:30 - 17:30
Novartis International AG Investor Relations P.O. Box CH-4002 Basel Switzerland
+41 61 324 79 44 investor.relations@novartis.com
More information
Local Media RelationsNovartis UK Press Office
+44 1276 698691pressoffice-uk.phgbfr@novartis.com
About Novartis home
Our Mission
Novartis in the UK
Novartis around the world
Company history
Awards
Investors
Our Products home
Therapy areas & products
Pharmaceuticals
Over the Counter
Vaccines & Diagnostics
Animal Health
Sandoz
Alcon
Corporate Responsibility home
Our commitment
Access to healthcare
Responsible business practices
Partnerships and support
Innovation home
Innovation at Novartis
Research & development
Scientific alliances
Animal research
News home
Media contacts
Media releases
Corporate publications
Featured news
Novartis newsrooms
Careers home
Careers at Novartis
Job search
Culture & values
Learning & development
Diversity & inclusion
International Biocamp
Breaking barriers: maximising research & development opportunities in the UK
27-Nov-2012 The ‘Breaking Barriers’ conference brought together leading clinicians and policy makers to discuss how to make the UK a more attractive environment for carrying out research and clinical trials.
Featured News
International Biocamp 2013
22-Apr-2013
The 2012 Novartis Annual report is now availableJan 2013
Novartis announces update to Company's Board of Directors to take effect in February 2012 9-Nov-2012
Novartis to start construction of new biotechnology facility in Singapore31-Oct-2012